LPCN: the cash flow

Net loss attributable to common shareholders

-2,622,595

-3,671,894

-2,370,084

-3,186,832

Depreciation expense

14,648

14,814

14,981

14,123

Stock-based compensation expense

58,145

65,398

53,034

53,256

Amortization of discounts on marketable investment securities

64,434

96,418

66,405

33,908

Accrued interest income

-10,346

97,222

-101,083

-6,460

License and royalties receivable

70,702

-1,025,993

1,053,985

-

Prepaid and other current assets

-106,051

-502,545

195,208

321,168

Accounts payable

-882,203

590,906

110,370

418,458

Accrued expenses

422,317

-591,259

486,707

63,888

Cash used in operating activities

-3,028,427

-2,257,137

-2,919,507

-2,985,723

Purchases of marketable investment securities

5,015,489

15,204,139

4,428,291

5,198,551

Maturities of marketable investment securities

6,500,000

5,300,000

6,000,000

5,900,000

Net cash provided by (used in) investing activities

1,484,511

-9,904,139

1,571,709

701,449

Net proceeds from sale of common stock through atm

1,507,738

11,964,056

2,652,600

141,334

Proceeds from stock option exercises

0

6,986

-

Cash provided by financing activities

1,507,738

11,971,042

2,652,600

141,334

Net decrease in cash and cash equivalents

-36,178

-190,234

1,304,802

-2,142,940

Cash and cash equivalents at beginning of period

5,015,608

5,205,842

3,901,040

6,205,926

Cash and cash equivalents at end of period

4,979,430

5,015,608

5,205,842

3,901,040

MyFinsight

Cash Flow Overview

Time Plot

Cash Flow

Cash Flow Overview

Time Plot

Cash Flow